Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene.

Vancomycin-resistant S. aureus was cultured from the exit site of a temporary dialysis catheter of a patient with diabetes, peripheral vascular disease, and persistent foot ulcers. The organism carried the vanA resistance gene, which may have come from the vancomycin-resistant Enterococcus faecalis that was also isolated from the patient, who had received vancomycin for several weeks.

[1]  B. Robinson-Dunn,et al.  Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group. , 1999, The New England journal of medicine.

[2]  S. P. Kachur,et al.  Malaria surveillance--United States, 1998. , 2001, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.

[3]  J. Miller,et al.  Pulsed-field gel electrophoresis as a replacement for bacteriophage typing of Staphylococcus aureus , 1995, Journal of clinical microbiology.

[4]  G. Eliopoulos,et al.  A cluster of VanD vancomycin-resistant Enterococcus faecium: molecular characterization and clinical epidemiology. , 1999, The Journal of infectious diseases.

[5]  F. Tenover,et al.  Staphylococcus aureus with reduced susceptibility to vancomycin isolated from a patient with fatal bacteremia. , 1999, Emerging infectious diseases.

[6]  Garner Js.  Guideline for isolation precautions in hospitals. Part I. Evolution of isolation practices, Hospital Infection Control Practices Advisory Committee , 1996 .

[7]  S. McAllister,et al.  Vancomycin-intermediate Staphylococcus aureus in a home health-care patient. , 2001, Emerging infectious diseases.

[8]  Mary Jane Ferraro,et al.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard , 2000 .

[9]  D. Persing,et al.  Diagnostic molecular microbiology : principles and applications , 1993 .

[10]  F. Tenover,et al.  Characterization of glycopeptide-resistant enterococci from U.S. hospitals , 1993, Antimicrobial Agents and Chemotherapy.

[11]  R. Carey,et al.  Staphylococcus aureus with reduced susceptibility to vancomycin--Illinois, 1999. , 2000, MMWR. Morbidity and mortality weekly report.

[12]  F. Tenover,et al.  Genetic Analyses of Mutations Contributing to Fluoroquinolone Resistance in Clinical Isolates ofStreptococcus pneumoniae , 2001, Antimicrobial Agents and Chemotherapy.

[13]  R. Weinstein,et al.  Vancomycin-intermediate and -resistant Staphylococcus aureus: what the infectious disease specialist needs to know. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  W. Noble,et al.  Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. , 1992, FEMS microbiology letters.

[15]  M. Arthur,et al.  Characterization of Tn1546, a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147 , 1993, Journal of bacteriology.

[16]  M. Delmée,et al.  Specific detection of methicillin-resistant Staphylococcus species by multiplex PCR , 1995, Journal of clinical microbiology.